Abstract
There is widespread consensus in the nephrologic literature that patients with uremia often suffer from dizziness and vertigo, less frequently from deafness (Bright, 1836; Rayer, 1840; Rosenstein, 1894; Morf, 1897; Volhard, 1931; Schreiner, and Maher, 1961). In so far as these symptoms are due to a coincident otitis media with subsequent labyrinthitis, they will not be dealt with, here; neither will we refer to the uremic neuro-encephalopathy or diffuse vascular lesions, both of which are often considered as the primary sources of auditory symptoms in terminal renal failure (Grahe, 1924; Strümpell-Seyfarth, 1930; Volhard, 1931; Mathes-Curschmann, 1947; Heyman et al., 1951; Beaney, 1964; Brod, 1964; Sarre, 1967; Heintz, 1968).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alport, A.C.: Hereditary familial congenital haemorrhagic nephritis. Brit. med. J. 1927 I, 504–506
Abenberg, I.K.: Alport’s syndrome: hereditary nephropathy, neurosensory hearing loss, and ocular abnormalities: a review. Univ. Mich. med. Cent. J. 33, 278–285 (1967).
Arenberg, I.K., Dodson, V.N., Falls, H.F., Stern, S.D.: Alport’s syndrome: re-evaluation of the associated ocular abnormalities and report of a family study. J. Pediat Ophthal.4, 21 (1967)
Arenberg, I.K., Johnsson, L.G., Ritter, F.N.: Alport’s syndrome: sensorineural hearing loss and hereditary nephropathy, cit. after Arenberg (1967).
Arnott, E.J., Crawfurd, M.D., Toghill, P.J.: Anterior lenticonus and Alport’s syndrome. Brit. J. Ophthal. 50, 390–403 (1966).
Barnett, R.J., Seligman, A.M.: Histochemical demonstration of protein bound sulfhydryl and disulfide groups of protein. J. nat. Cancer Inst. 14, 769 (1954).
Beaney, G. P.E.: Otolaryngeal problems arising during the management of severe renal failure. J. Laryng. 78, 507–515 (1964).
Bergstrom, L.V., Jenkins, P., Sando, I., English, G.M.: Hearing loss in renal disease; clinical and pathological studies. Ann. Otol. 82, 555–576 (1973).
Berlyne, G.M.: Familial Nephritis. Manchester med. Gaz. 41, 26 (1962).
Bosher, S.K., Smith, C., Warren, R.L.: The effect of ethacrynic acid upon the cochlear endolymph and stria vascularis, a preliminary report. Acta oto-laryng. (Stockh.) 75, 184–191 (1973).
Braun, F.C., Bayer, J.F.: Familial nephrosis associated with deafness and congenital urinary tract anomalies in siblings. J. Pediat. 60, 33 (1962).
Bright, R.: Cases and observations illustrative of renal disease accompanied by the secretion of albuminous urine. Guy’s Hosp. Rep. 1, 338–379 (1836).
Brod, J.: Die Nieren. Physiologie, klinische Physiologie und Klinik. Berlin: VEB Verlag Volk und Gesundheit 1964.
Brown, R.D.: Cochlear N1 depression produced by the sodium salts of ethacrynic acid and its cysteine adduct. Neuropharmacology 12, 967–974 (1973).
Cassady, G., Brown, K., Cohen, M., DeMaria, W.: Hereditary renal dysfunction and deafness. Pediatrics 35, 967 (1965).
Chappel, J. A., Kelsey, W.M.: Hereditary nephritis. Amer. J. Dis. Child 99, 401–407 (1960).
Cohen, M.M., Cassady, G., Hanna, B.L.: Genetic study of hereditary renal dysfunction with associated nerve deafness. Amer. J. hum. Genet. 13, 379–389 (1961).
Cohn, E.S.: Ethacrynic acid. Arch. Otolaryng. 97, 300 (1973).
Cohn, E.S., Gordes, E.H., Brusilow, S.W.: Ethacrynic acid effects on the composition of cochlear fluids. Science 171, 910–911 (1971).
Corti, A.: Recherches sur l’organe de l’ouie des mammifères. Z. wiss. Zool. 3, 109–169 (1851).
Crawfurd, M.D., Toghill, P.J.: Alport’s syndrome of hereditary nephritis and deafness. Quart. J. Med. 37, 563–576 (1968).
Crifo, S.: Ototoxicity of sodium ethacrynate in the guinea pig. Arch. Oto-Rhino-Laryng. 206, 27–38 (1973).
Deetjen, P.: Micropuncture studies of diuretics in rats. Proc. 3rd Int. Congr. Nephrology, Washington 1966 (Basel-New York 1967), S. 250.
Dickinson, W.H.: Disease of the kidney, characterized by albuminuria. In: Albut’s, a system of medecine, Vol. 4, 352. New York; McMillan 1875.
Dieulafoye, G.: France méd. 24, 122 (1877), zit. n. Kelemen (1957).
Dilling, J.M., Nakashima, T., Snow, J.B.Jr.: Effect of ethacrynic acid on endolymphatic dc potential. Arch. Otolaryng. 98, 183–186 (1973).
Don Brown, R.: Ototoxicity caused by ethacrynic acid and furosemide. Minerva otorinolaring. 22, 213–221 (1973).
Dubach, U.C., Gsell, O.: Alport’s syndrome. Lancet 1962 I, 159.
Dubach, U.C., Minder, F.C., Antener, I.: Familial nephropathy and deafness: First observation of a family and close relatives in Switzerland. Helv. med. Acta 33, 36–43 (1966).
Federspil, P., Mausen, H.: Experimentelle Untersuchungen über die Ototoxizität eines starken Salidiuretikums (Ethacrynsäure). Mschr. Ohrenheilk. 107, 256–263 (1973).
Federspil, P., Mausen, H.: Experimentelle Untersuchungen zur Ototoxicität des Furosemids. Res. exp. Med. 161, 175–184 (1973).
Fischer, W., Fritzsche, S., Schubel, F., Wurster, U.: Alport-Syndrom. Neurologische und psychiatrische Betrachtungen. Med. Welt (Stuttg.) 21, 2058–2060 (1970).
Flower, R.M.: Familial coincident renal disease and hearing loss. J. Speech Dis. 29, 329–333 (1964).
Fujita, S., Hayden, R.C.: Alport’s syndrome; temporal bone report. Arch. Otolaryng. 90, 453–466 (1969).
Gayer, J.: Die renale Excretion des neuen Diureticums Furosemid. Klin. Wschr. 43, 898 (1965).
Gekle, D., Essler, H., Brunner, H.: Familiäre Nephropathie und Schallempfindungsschwerhörigkeit (Alport-Syndrom). Arch. Kinderheilk. 178, 290–302 (1969).
Goetz, O., Karl, H.J., Dattenberg, L.: Familiäre Hämaturie und Innenohrschwerhörigkeit. Z. Kinderheilk. 94, 63–97 (1965).
Goldbloom, R. B., Fraser, F.C., Wafgh, D., Aranovitch, M., Wigglesworth, D.: Hereditary renal disease associated with nerve deafness and ocular lesions. Pediatrics 20, 241–252 (1957).
Goldbloom, R.B., Haberfelde, G.C.: Hereditary nephritis: report of a kindred. New Engl. J. Med. 261, 734 (1959).
Goldman, W.J., Bielinski, T.C., Mattis, P.A.: Cochlear microphonic potential response of the dog to diuretic compounds. Toxicol, appl. Pharmacol. 25, 259–266 (1973).
Graham, J.B.: Hereditary chronic kidney disease: an alternative to partial sex linkage in the Utah kindred. Amer. hum. Genet, 11, 333 (1959).
Grahe, K.: Hör- und Gleichgewichtsstörungen bei Nephritis. Z. Hals-Nas.-Ohrenheilk. 8, 375–471 (1924).
Gregg, J.B., Becker, S.J.: Concomitant progressive deafness, chronic nephritis, and ocular lens disease. Arch. Ophthal. 69, 293–299 (1963).
Gurrier, Déjan, Y.: Le syndrome familial néphropathie-surdité. Rev. Laryng. 85, Suppl. 925–935 (1964).
Gussen, R.: Scala vestibuli partition with deafness and renal disease. Ann. Otol. Rhinol. 82, 871–875 (1973).
Hanson, P.A., Farber, R.E., Armstrong, R.A.: Distal muscle wasting, nephritis, and deafness. Neurology 20, 426–434 (1970).
Hajdu, P., Häussler, A.: Untersuchungen mit dem Salidiuretikum 4-Chlor-N-(2-furylmethyl) -5-sulfanylanthranylsäure. Arzneimittel-Forsch. 14, 709–710 (1964).
Haubrich, J., Schätzle, W.: Zur Frage histochemischer Veränderungen der Meerschweinchenschnecke unter dem Einfluß von Diuretica. Arch. klin. exp. Ohr.-, Nas, — u. Kehlk. Heilk. 196, 319–324 (1970).
Heidland, A., Klütsch, K., Moormann, A., Hennemann, H.: Möglichkeiten und Grenzen hochdosierter Diuretikatherapie bei hydropischer Niereninsuffizienz. Dtsch. med. Wschr. 94, 1568–1574 (1969).
Heidland, A., Wigand, M.E.: Einfluß hoher Furosemiddosen auf die Gehörfunktion bei Urämie. Klin. Wschr. 48, 1052–1056 (1970).
Heidland, A., Hennemann, H., Wigand, M.E.: Dosiswirkung und optimale Infusionsgeschwindigkeit hoher Furosemidgaben bei terminaler Niereninsuffizienz. 4. Symposium über Nephrologie, Freiburg 1970. Edit. R. Kluthe, Stuttgart: G. Thieme (1971).
Heintz, R.: Nieren-Fibel für Klinik und Praxis. Stuttgart: Thieme 1968.
Hennemann, H., Bloemertz, B., Heidland, A.: Studies on natriuretic properties of methyl-guanidine. Z. exp. Med. (1972).
Heymann, A., Patterson, J.L., Jones, R. W.: Cerebral circulation and metabolism in uremia. Circulation 3, 558–563 (1951).
Hilson, D.: Malformations of the ears as a sign of malformations of the genito-urinary tract. Brit. med. J. 1957 II 785.
Hurst, A.: Hereditary familial congenital hemorrhagic nephritis, occurring in sixteen individuals in three generations. Guy’s Hosp. Rep. 73, 368 (1923).
Johnson, W.J., Hagan, P.J.: Hereditary nephropathy and loss of hearing. Arch. Otolaryng. 82, 166–172 (1965).
Jung, W., Machold, W.: Zum Einfluß von Salidiuretica auf die Cochlea-Mikrophonpotentiale beim Meerschweinchen. Arch. klin. exp. Ohr.-, Nas.- u. Kehlk. Heilk. 196, 307–314 (1970).
Just, L., Schieche, M., Weigl, E.: Das Syndrom familiärer erblicher Nephropathie mit Innenohrschwerhörigkeit (Alport-Syndrom). Med. Welt (Stuttg.) 40, 2340–2344 (1967).
Kaku, Farmer, J.C.Jr., Hudson, W.R.: Ototoxic drug effects on cochlear histochemistry. Arch. Otolaryng. 98, 282–286 (1973).
Kelemen, G.F.: Embryonaler Ohrbefund nach operativer Entfernung wegen mütterlicher Nephritis. Mschr. Ohrenheilk. 91, 136–145 (1957).
Kidd, J.: The inheritance of Bright’s disease of the kidney. Practitioner 29, 104 (1882).
Klotz, R.E.: Congenital hereditary kidney disease and hearing loss: a case history. Arch. Otolaryng. 69, 560–562 (1959).
Kohonen, A., Jauhiainen, T., Tarkkanen, J.: Experimental deafness caused by ethachrynic acid. Acta otolaryng. (Stockh.) 70, 187–189 (1970).
Komorn, R.M., Cafruny, E. J.: Ethacrynic acid: diuretic property coupled to reaction with sulfhydryl groups of renal cells. Science 143, 133 (1964).
Konigsmark, B.W.: Hereditary deafness in man. New Engl. J. Med. 281, 827–832 (1969).
Kreusser, W., Heidland, A., Hennemann, H., Knauf, H., Wigand, M.E.: Speichelelektrolyte und Flußrate bei terminaler Niereninsuffizienz. Arch. klin. exp. Ohr.-, Nas.- u. Kehlk. Heilk. 199, 614–618 (1971).
Krickstein, H.I., Gloor, F.J., Balogh, K.: Renal pathology in hereditary nephritis with nerve deafness. Arch. Path. 82, 506–517 (1966).
Lachhein, L., Kemnitz, P., Büttner, H., Thal, W., Witkowski, R.: Erbliche Nephritis mit Innenohrschwerhörigkeit (Alport-Syndrom). Dtsch. med. Wschr. 93, 1891–1896 (1968).
Lange, K., Lonergan, E.T., Semar, M., Sterzel, R.B.: Transketolase inhibition as a mechanism in uremic neuropathy. 1. Internat. Urämie-Symposium über Pathogenese, Stoffwechsel, Klinik und Ernährung, Freiburg 1971 (in press).
Lederer, L.: Die Erkrankungen des Gehörorgans in ihren Beziehungen zu Erkrankungen des Stoffwechsels etc. In: A. Denker, O. Kahler’s Handb. Hals-Nasen-Ohrenheilk. VI, I. Teil, S. 654. Berlin: J. Springer 1926.
Lemieux, G., Neehmeh, J. A.: Charcot-Marie-Tooth disease and nephritis. Canad. med. Ass. J. 97, 1193 (1967).
Levinson, R.M., Capps, M.J., Mathog, R.H.: Ethacrynic acid, furosemide, and vestibular caloric responses. Ann. Otol. 83, 223–229 (1974).
Lynch, R.C.: Otologic signs in general diseases. New Orleans Med. Surg. J., July 1912, ref. Internat. Zbl. Ohrenheilk. 11, 18 (1913).
Maher, J.F., Schreiner, G.E.: Studies on ethacrynic acid in patients with refractory edema. Ann. intern. Med. 62, 15–29 (1965).
Mamou, H.: Maladie périodique familiale avec néphropathie et surdité. Sem. Hop. Paris 42, 3363–3366 (1966).
Matthes, M., Curschmann, H.: Lehrbuch der Differentialdiagnose Innerer Krankheiten. 12. Aufl. Berlin-Göttingen-Heidelberg: Springer 1947.
Mathog, R.H., Klein, W.J.: Ototoxicity of ethacrynic acid and aminoglycoside antibiotics in uremia. New Engl. J. Med. 280, 1223–1224 (1969).
Mathog, R.H., Thomas, W.G., Hudson, W.R.: Ototoxicity of new and potent diuretics. A preliminary study. Arch. Otolaryng. 92, 7–13 (1970).
Matz, G.J., Beal, D.D., Krames, L.: Ototoxicity of ethacrynic acid. Arch. Otolaryng. 90, 152–158 (1969).
Matz, G. J., Naunton, R.F.: Ototoxic drugs and poor renal function. J. Amer. med. Ass. 206, 2119 (1968).
Meents, O.: Gehör- und Gleichgewichtsfunktion bei Urämie und unter hochdosierter Furose-midtherapie. Inauguraldissertation, Würzburg 1972.
Meriwether, W.D., Mangi, R.J., Serpick, A.A.: Deafness following standard intravenous dose of ethacrynic acid. J. Amer. med. Ass. 216, 795–798 (1971).
Miller, G.W., Joseph, D.J., Cozad, R.L., McCabe, B.F.: Alport’s syndrome. Arch. Otolaryng. 92, 419–436 (1970).
Minder, F.C., Dubach, U.C., Antener, I.: Hereditäre Nephropathie mit Schwerhörigkeit. Z. klin. Chem. 158, 601 (1965a).
Minder, F.C., Dubach, U.C., Antener, L.: Familiäre Nephropathie und Schwerhörigkeit: erste Beobachtung in der Schweiz. Helv. med. Acta 32, 404–405 (1965b).
Mitschke, H., Schmidt, P., Kopsa, Zazgornik, J.: Effekt der Nierentransplantation auf die urämische Hörstörung. Dtsch. med. Wschr. 98, 2445–2447 (1973).
Morf, J.: Die Krankheiten des Ohres beim acuten und chronischen Morbus Brightii. Z. Ohren-heilk. 30, 313–343 (1897).
Muckle, T.J., Wells, M.: Urticaria, deafness, and amyloidosis: a new heredo-familial syndrome. Quart. J. Med. 31, 235–248 (1962).
Müsebeck, K., Schätzle, W.: Die Verteilung der Sulfhydryle und der Disulfide in der Meerschweinchenschnecke. Arch. Ohr.-, Nas.- u. Kehlk. Heilk. 181, 75 (1963).
Murrow, P.J.: Hereditary nephritis: Report of a kindred. Amer. J. Med. 35, 737–748 (1963).
Nieth, H.: Beitrag zum Syndrom der hereditären Hämaturie, Nephropathie und Schwerhörigkeit. Verh. Dtsch. Ges. inn. Med. 65, 664–667 (1959).
Nieth, H.: Hereditäre und endemische Nephropathien vorwiegend interstitieller Lokalisation. In: Schwiege, H.C.Ed.: Handb. Inn. Med. VIII. Nierenkrankheiten, Teil 2, S. 909–941. Berlin-Heidelberg-New York: Springer 1968.
Oda, M., Preciado, M.C., Quick, C.A., Paparella, M.M.: Labyrinthine pathology of chronic renal failure in patients treated with hemodialysis and kidney transplantation. Laryngoscope 84, 1489–1506 (1974).
Ohlsson, L.: Congenital renal disease, deafness, and myopia in one family. Acta med. scand. 174, 77 (1963).
Onisawa, J., Sato, H., Suzuki, Y.: Paediat. Univ. Tokyo 11, 9 (1965), cit. n. Crawfurd and Toghill (1968).
Paparella, M., Winter, L.: Sensorineural deafness in children. Trans. Amer. Acad. Ophthal. Otolaryng. 72, 782–788 (1968).
Pease, D.C.: Infolded basal plasma membranes found in epithelia noted for their water transport. J. Biophys. Biochem. Cytology 2, Suppl. 203–208 (1956).
Perkhoff, G. T., Nugent, C.A., Dolowitz, D.A., Stephens, F.E., Carnes, W., Tyler, F.H.: Follow-up study of hereditary chronic nephritis. Arch, intern. Med. 102, 733 (1958).
Perkoff, G.T., Stephens, F.E., Dolowitz, D.A., Tyler, F.H.: A clinical study of hereditary interstitial pyelonephritis. Arch, intern. Med. 88, 191–200 (1951).
Perrin, D.: Alport’s syndrome. Ann. Oculist. 197, 329 (1964).
Pillay, V.K.G., Schwartz, F.D., Aimi, K., Kark, R.M.: Transient and permanent deafness following treatment with ethacrynic acid in renal failure. Lancet 1969, 77–79.
Piorry, L’Heritier: Traité des altérations du sang. Paris 1840, cit. n. Sarre (1967).
Poli, M.: Nephropathie médicale bilaterale familiale à evolution chronique. Helv. med. Acta 22, 109 (1955).
Prazma, J., Thomas, W. G., Fischer, N.D., Preslar, M. J.: Ototoxicity of the ethacrynic acid. Arch. Otolaryng. 95, 448–456 (1972).
Prazma, J., Thomas, W.G.: Ethacrynic acid. Reply. Arch. Otolaryngol. 97, 300 (1973).
Prill, A.: Die neurologische Symptomatologie der Niereninsuffizienz. Schriftenreihe Neurologie, Neurology Series, Vol. 2. Berlin-Heidelberg-New York: Springer 1969.
Quick, C.A., Duvall, A. J.: Early changes in the cochlear duct from ethacrynic acid: An electronmicroscopic evaluation. Laryngoscope 80, 954–965 (1970).
Quick, C.A., Fish, A., Brown, C.: The relationship between cochlea and kidney. Laryngoscope 83, 1469–1482 (1973).
Ransome, J., Ballantyke, J.C., Shaldon, S., Bosher, S.K., Hallpike, O.S.: Perceptive deafness in subjects with renal failure treated with hemodialysis and polybrene: a clinico-pathological study. J. Laryng. 80, 651–677 (1966).
Rauch, S.: Biochemie des Hörorgans. Stuttgart: Thieme 1964.
Rayer: Traité des maladies des reins, 1840, cit. n. Lederer (1926).
Rosenstein,: Nierenkrankheiten, 4. Aufl., 1894, cit. n. Lederer (1926).
Ruska, H., Moore, D.H., Weinstock, J.: The base of the proximal convoluted tubule cells of rat kidney. J. Biophys. Biochem. Cytol. 2, 249–254 (1957).
Samuelsson, F.: Über hereditäre Nephritis und über den Hereditätsbegriff im allgemeinen. Virchows Arch. path. Anat. 59, 257 (1874).
Sarre, H.: Nierenkrankheiten. Physiologie, Pathophysiologic, Untersuchungsmethoden, Klinik und Therapie, 3. Aufl. Stuttgart: Thieme 1967.
Schafer, I.A., Scriver, C.R., Efron, M.L.: Familial hyperprolinemia, cerebral dysfunction and renal anomalies occurring in a family with hereditary nephropathy and deafness. New Engl. J. Med. 267, 51 (1962).
Schmidt, P.H.: Presbyacusis. Internat. Audiol. Suppl. 1 (1967).
Schmidt, P., Friedman, I.S.: Adverse effects of ethacrynic acid. N. Y. St. J. Med. 67, 1438–1442 (1967).
Schneider, W. J., Becker, E.L.: Acute transient hearing loss after ethacrynic acid therapy. Arch, intern. Med. 117, 715–717 (1966).
Schreiner, G.E., Mäher, J.F.: Uremia: Biochemistry, pathogenesis, and treatment. Springfield, Ill.: Ch. Thomas 1961.
Schreiner, L.: Klinische und histologische Untersuchungen zum Alport-Syndrom. Arch. klin. exp. Ohren-, Nas.- u. Kehlk. Heilk. 191, 618–622 (1968).
Schwartz, F.D., Pillay, V.K.G., Kark, R.M.: Ethacrynic acid: its usefulness and untoward effects. Amer. Heart J. 79, 427–428 (1970).
Schwartz, G.H., David, D.S., Riggio, R.R., Stenzel, K.H., Pubin, A.L.: Ototoxicity induced by furosemide. New Engl. J. Med. 282, 1413–1414 (1970).
Schwartze, H.: Ein Fall von Bluterguß in die Paukenhöhle bei Morbus Brightii. Arch. Ohrenheilk. 4, 12–14 (1869).
Scriver, C.R., Schäfer, I. A., Efron, M.E.: New renal tubular amino acid transport system and new hereditary disorder of amino acid metabolism. Nature (Lond.) 192, 672 (1961).
Scriver, C.R.: Evidence for a renal tubular amino acid transport system common to glycine, L-proline, and hydroxy-L-proline. J. clin. Invest. 40, 1080 (1961).
Scriver, C.R.: Renal tubular transport of proline, and glycine in health and in familial hyperprolinemia. J. clin. Invest. 43, 374 (1964).
Senior, B., Gillis, S.S.: The syndromes of total lipodystrophy and of partial lipodystrophy. Pediatrics 33, 593–612 (1964).
Shaw, R.F., Glover, R.A.: Abnormal segregation in hereditary renal disease with deafness. Amer. J. hum. Genet. 13, 89–97 (1961).
Silverstein, H., Yules, R.B.: The effect of diuretics on cochlear potentials and inner ear fluids. Laryngoscope 81, 873–888 (1971).
Smith, C.A.: Structure of the stria vascularis and the spiral prominence. Ann. Otol. 66, 521–536 (1957).
Sohar, E.: Heredofamilial syndrome characterized by renal disease, inner ear deafness, and ocular changes. Harefuah 47, 161 (1954).
Sohar, E.: Renal disease, inner ear deafness and ocular changes: new heredo-familial syndrome. Arch, intern. Med. 97, 627–630 (1956).
Spoendlin, H.: Vascular stria. In: Iurato, S.: Submicroscopic structure of the inner ear. Oxford-London-New York: Pergamon Press 1967.
Stephens, F.E., Perkoff, G.T.: Partially sex-linked dominant inheritance of interstitial pyelonephritis. Am. J. hum. Genet. 3, 303 (1951).
Strümpell-Seyfarth: Lehrbuch der speziellen Pathologie und Therapie der inneren Krankheiten, 29. u. 30. Aufl., IL Band, S. 14. Leipzig: F. C. W. Vogel (1930).
Sturtz, G.S., Burke, E.C.: Hereditary hematuria, nephropathy, and deafness; preliminary report. New Engl. J. Med. 254, 1123–1126 (1956).
Suzuki, Y., Kanzaki, J.: Alport’s syndrome of familial kidney disease with deafness. J. Oto-Rhino-Laryng. Soc. Jap. 67, 1175 (1964).
Symposium on uremic toxins. Guest Editors: Welt, L.G., Black, H.R., Krueger, K.K., Monterey, Calif. (1970). Arch, intern. Med. 126, 733–910 (1970).
Taylor, W.C.: Congenital deformity of the ears and kidneys. Canad. Med. J. 93, 107 (1965).
Thalmann, R., Kusakari, J., Miyoshi, T.: Dysfunctions of energy releasing and consuming processes of the cochlea. Laryngoscope 83, 1690–1712 (1973).
Thoenes, W.: Die Mikromorphologie des Nephron in ihrer Beziehung zur Funktion. Klin. Wschr. 39, 504–518; 827–839 (1961).
Thoenes, W.: Transportwege in den Harnkanälchen der Säugerniere. In: Funktionelle und morphologische Organisation der Zelle. Sekretion und Exkretion, S. 315–341. Berlin-Heidelberg-New York: Springer 1965.
Traut, G., Jutzler, G.A.: Urämie. Klinik und Therapie. Fortschr. Med. 88, 227–230 (1970).
Turner, J.S., Jr.: Hereditary hearing loss with nephropathy (Alport’s syndrome). Acta Otolaryngol. Suppl. 271, 1–26 (1970).
Tyler, H.R.: Neurologic disorders in renal failure. Amer. J. Med. 44, 734–748 (1968).
Tyler, H.R.: Neurologic disorders seen in the uremic patient. Arch, intern. Med. 126, 781–786 (1970).
Tyson, J.: A treatise on Bright’s disease and diabetes. Philadelphia: Lindsay and Blakiston 1881.
Van Buchen, F., Beetstra, A.: Hereditary renal disease associated with deafness: Alport’s syndrome. Proc. Kon. Ned. Akad. Wet. Ser. C 68, 350 (1965).
Volhard, F.: Die Urämie. In: Die doppelseitigen hämatogenen Nierenerkrankungen. Handb. Inn. Med. Bd. VI, 1, 2. Aufl. Berlin: Springer 1931.
Wallace I.R., Jones, I.H.: Familial glomerulonephritis and amino-aciduria. Lancet 1960 I, 941.
Walloch, R.A., Anthony, J., Gibbons, N.: Depression of the evoked cortical potential by ethacrynic acid. Laryngoscope 84, 256–266 (1974).
Whalen, R.E., Huang, S., Peschel, E.: Hereditary nephropathy: deafness and renal foam cells. Amer. J. Med. 31, 171–186 (1961).
Wigand, M.E., Heidland, A.: Ototoxic side-effects of high doses of furosemide in patients with uremia. IV. Internat. Congr. Nephrology, Stockholm, 1969. Postgrad, med. J. 47, April 1971, Suppl. 54–56.
Wigand, M.E., Heidland, A.: Akute, reversible Hörverluste durch rasche, hochdosierte Furosemidinfusionen bei terminaler Niereninsuffizienz. Arch. klin. exp. Ohr.-, Nas.- u.Kehlk. Heilk. 196, 314–319 (1970).
Wigand, M.E., Meents, O., Heidland, A.: Cochleovestibuläre Störungen bei Patienten mit terminaler Niereninsuffizienz IV. Symposium über Niereninsuffizienz, Innsbruck, 1971. Edit. P. v. Dittrich, F. Skrabal. Friedberg: C. Bindernagel, 1971.
Wigand, M.E., Meents, O., Hennemann, H., Heidland, A.: Kochleo-vestibuläre Störungen bei Urämie in Beziehung zum Elektrolytstoffwechsel und Glomerulumfiltrat. Schweiz. med. Wschr. 102, 477–482 (1972).
Williamson, D.A.J.: Alport’s syndrome of hereditary nephritis with deafness. Lancet 1961 II, 1321–1323.
Wilson, K. S., Juhn, S. K.: The effect of etharcrynic acid on perilymph Na and K (Preliminary report). Pract. oto-rhino-larnyg. 32, 279–287 (1970).
Winter, L.E., Cram, B.M., Banovetz, J.D.: Hearing loss in hereditary renal disease. Arch. Otolaryng. 88, 238–241 (1968).
Wood, J.J., Knight, L.W.: A family with Alport’s syndrome of hereditary nephritis and deafness. Med. Mschr. 20, 227–235 (1966).
Yassin, A., Badry, A., Fatt-Hi, A.: The relationship between electrolyte balance and cochlear disturbances in cases of renal failure. J. Laryng. 84, 429–435 (1970a).
Yassin, A., Badry, A., Fatt-Hi, A.: The role of electrolyte balance on vestibular disturbances in case of renal failure. J. Laryng. 84, 437–442 (1970b).
Yassin, A., Safwat, F., Fatt-Hi, A.: Ear, nose and throat manifestations in cases of renal failure treated by dialysis, hemodialysis, and peritoneal dialysis. Ann. Otol. 75, 192–201 (1966).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1976 Springer-Verlag Berlin · Heidelberg
About this chapter
Cite this chapter
Wigand, M.E. (1976). Hearing and Equilibrium in Renal Failure. In: Keidel, W.D., Neff, W.D. (eds) Auditory System. Handbook of Sensory Physiology, vol 5 / 3. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-66082-5_6
Download citation
DOI: https://doi.org/10.1007/978-3-642-66082-5_6
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-66084-9
Online ISBN: 978-3-642-66082-5
eBook Packages: Springer Book Archive